Erste Asset Management GmbH increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 2,213.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,130 shares of the exchange traded fund’s stock after acquiring an additional 22,130 shares during the period. Erste Asset Management GmbH’s holdings in SPDR S&P Biotech ETF were worth $2,820,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently bought and sold shares of XBI. Legacy Wealth Managment LLC ID acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $32,000. Greykasell Wealth Strategies Inc. acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $35,000. Ballast Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $36,000. Creative Financial Designs Inc. ADV acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $39,000. Finally, MCF Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $46,000.
SPDR S&P Biotech ETF Price Performance
Shares of XBI stock opened at $131.38 on Wednesday. The business’s fifty day moving average price is $132.23 and its 200 day moving average price is $126.86. SPDR S&P Biotech ETF has a 1-year low of $80.90 and a 1-year high of $139.19. The firm has a market capitalization of $8.38 billion, a PE ratio of 11.47 and a beta of 0.85.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
